netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.04.01  Expand sub section  Drugs for urinary retention
07.04.01  Expand sub section  Alpha-blockers
Alfuzosin tabs, m/r tabs

View adult BNF  View SPC online
Formulary
   
Doxazosin tabs

View adult BNF  View SPC online
Formulary
   
Indoramin tabs

View adult BNF  View SPC online
Formulary
   
Prazosin tabs

View adult BNF  View SPC online
Formulary
   
Tamsulosin m/r caps

View adult BNF  View SPC online
Formulary Approved for licensed uses, and the following off-label indication:
Medical expulsive therapy of urolithiasis (including extracorporeal shockwave lithotripsy) in men and women (consultant use only).
Dose: 400 micrograms daily for 7-14 days
   
07.04.01  Expand sub section  Parasympathomimetics
 ....
 Non Formulary Items
Combodart (dutasteride and tamsulosin)


View adult BNF  View SPC online
Non Formulary
Grey
The APC recommend that if alpha blocker and 5-alpha reductase inhibitor combination therapy is required finasteride and tamsulosin should be used

Link  APC recommendation: Combodart for benign prostatic hyperplasia (not approved)  
  
Key
note Notes First Choice Item First Choice item
Section Title Section Title (top level) Non Formulary Item Non Formulary section
Section Title Section Title (sub level)
Cytotoxic Drug
Cytotoxic Drug
Restricted Drug
Restricted Drug
CD
Controlled Drug
Unlicensed Drug
Unlicensed
High Cost Medicine
High Cost Medicine
click to search medicines.org.uk
Link to SPCs
click to search medicines.org.uk
Link to adult BNF
Track Changes
Display tracking information
click to search medicines.org.uk
Cancer Drugs Fund
Cancer Drugs Fund
   

 

Traffic Light Status Information

Status Description
  Red   Specialist Prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   
  Amber 1   Treatment can be initiated in primary care after a recommendation from an appropriate specialist  
  Amber 2   Specialist initiation followed by maintenance prescribing in primary care  
  Amber 3   Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  
  Green   Specialist and non-specialist initiation  
  Grey   Not recommended for prescribing  

netFormulary